HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intrinsic differences in cisplatin sensitivity of head and neck cancer cell lines: Correlation to lysosomal pH.

AbstractBACKGROUND:
Cisplatin treatment is beneficial for approximately 20% of patients with head and neck squamous cell carcinoma (HNSCC). Tools to predict the clinical outcome and evaluate intrinsic cisplatin sensitivity are, therefore, required.
METHODS:
Cisplatin sensitivity, lysosomal pH, and cell death pathway was studied in 5 HNSCC lines and compared with normal oral keratinocytes.
RESULTS:
We identified a linear relationship between lysosomal pH and cisplatin sensitivity. Reduced lysosomal acidification was correlated to decreased expression of the V(0)V(1)-ATPase B2 subunit, which is part of the lysosomal acidifying complex. Cisplatin caused apoptosis accompanied by lysosomal membrane permeabilization, and inhibition of lysosomal proteases (cathepsins) partly prevented cell death.
CONCLUSION:
Cisplatin-induced apoptosis of HNSCC is more efficient in cell lines with low lysosomal pH and is mediated by the release of lysosomal content. Lysosomal pH and expression of V(0)V(1)-ATPase subunits are possible future markers of intrinsic cisplatin sensitivity.
AuthorsCathrine Nilsson, Karin Roberg, Roland C Grafström, Karin Ollinger
JournalHead & neck (Head Neck) Vol. 32 Issue 9 Pg. 1185-94 (Sep 2010) ISSN: 1097-0347 [Electronic] United States
PMID20029982 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cisplatin
Topics
  • Apoptosis (drug effects)
  • Blotting, Western
  • Carcinoma, Squamous Cell (drug therapy, pathology)
  • Cell Death (drug effects)
  • Cell Line, Tumor (drug effects)
  • Cisplatin (pharmacology)
  • Drug Resistance, Neoplasm
  • Fluorescent Antibody Technique
  • Head and Neck Neoplasms (drug therapy, pathology)
  • Humans
  • Hydrogen-Ion Concentration
  • Lysosomes (drug effects, metabolism)
  • Reference Values
  • Sensitivity and Specificity
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: